Coca-Cola proved to be the strongest US brand by posting a Brand Strength Index (BSI) score of 93.3, higher than Google, YouTube, Amazon, and Deloitte, according to a TradingPlatforms.com analysis.
The BSI rating also places Coca-Cola 2.2 points ahead of rival beverage company Pepsi.
The Brand Loyalty and Recommendation Forecast data, which reflects consumer perceptions, preferences, and intentions both online and offline, is the basis for the BSI score ranking.
Additionally, the renowned beverage business has a correspondingly prestigious AAA+ rating.
TradingPlatforms’ financial expert Edith Reads attributed Coca-Cola’s brand strength to the prominence of its core drink in the consumer’s mind, and recent innovations such as new flavors and lower sugar variants.
The BSI score, she continued, is a gauge of consumer loyalty, which can only be attained by having a remarkable level of brand awareness and high consumer approval ratings.
To satisfy consumer demand in a period of growing health consciousness, the company has concentrated on offering low-nutrition and alternative products like Coke Zero.
In a time of disrupted supply chains, it has also strategically chosen to use e-commerce to guarantee brand availability. In addition to its strong product strategy, which helped Coca-Cola ascend to the top, the company's digital strategy has also increased sales.


TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
U.S. Stock Futures Slide as Tech Rout Deepens on Amazon Capex Shock
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility
Fed Governor Lisa Cook Warns Inflation Risks Remain as Rates Stay Steady
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease 



